Stay updated on Nivolumab and Ipilimumab in Advanced Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Ipilimumab in Advanced Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Ipilimumab in Advanced Liver Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.0%
    Check dated 2026-11-02T12:54:32.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A government-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the study record.
    Difference
    0.3%
    Check dated 2026-10-26T13:37:04.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The website footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.0%
    Check dated 2026-10-19T13:43:40.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov site as revision v3.7.1 instead of v3.7.0.
    Difference
    0.0%
    Check dated 2026-10-12T14:56:43.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The study record history now shows a new revision entry 'Revision: v3.7.0'. The previous revision 'Revision: v3.6.6' is removed from view, updating the versioning state of the record.
    Difference
    0.0%
    Check dated 2026-09-21T22:13:57.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Version 89 shows the study as Completed with updated Study Status and Recruitment Status fields, replacing the previous Active, not recruiting status from the prior revision.
    Difference
    0.3%
    Check dated 2026-08-31T17:13:56.000Z thumbnail image

Stay in the know with updates to Nivolumab and Ipilimumab in Advanced Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Ipilimumab in Advanced Liver Cancer Clinical Trial page.